Eton Pharmaceuticals (ETON) Depreciation & Amortization (CF) (2018 - 2025)

Eton Pharmaceuticals has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $1.0 million in Q4 2025.

• Quarterly Depreciation & Amortization (CF) rose 186.48% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (up 252.88% YoY) and the FY2025 annual result came in at $4.0 million, up 252.88% from the prior year.
• Depreciation & Amortization (CF) rose to $1.0 million in Q4 2025 per ETON's latest filing, from $1.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.2 million in Q2 2022 and troughed at $85000.0 in Q2 2021.
• A 5-year average of $416350.0 and a median of $243000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) surged 1277.65% in 2022, then slumped 85.31% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $137000.0 in 2021, then surged by 83.94% to $252000.0 in 2022, then grew by 28.97% to $325000.0 in 2023, then grew by 9.23% to $355000.0 in 2024, then surged by 186.48% to $1.0 million in 2025.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1.0 million, $1.0 million, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.